Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EPW writ of certiorari

Executive Summary

Supreme Court declines to hear Genetics Institute's EPO petition. The justices offered no comment on the petition denial; however, historically, the Supreme Court has refused to hear patent cases. . . . Rep. Stark on Epogen: During a House Ways & Means Committee hearing on health care reform Oct. 10, the California Democrat decried the high price of the product, noting that Medicare will pay $ 400 mil. for Epogen next year. Stark asked HHS Secretary Sullivan whether the Bush Administration intends "to use Medicare as a form of industrial policy." Sullivan responded that the drug is priced "exceedingly high" but pointed out that EPO is an orphan product for a rare disease. After arranging with Amgen for development, HHS wanted to avoid "changing goalposts once the game was begun," Sullivan said. . . .
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel